Fundraising Fox

Biocept

San Diego, US · Founded 2013 · Delaware corporation

Biotech

Founders & leadership

MW
Michael W NallExecutive
LA
Lyle ArnoldExecutive
RT
Raaj TrivediExecutive
VS
Veena SinghExecutive
MF
Mark FolettaExecutive

Board

IR
Ivor RoystonBoard director
EN
Edward NeffBoard director
BA
Bruce A HuebnerBoard director
MA
Marsha A ChandlerBoard director
DF
David F HaleBoard director
MF
M Faye WilsonBoard director
BE
Bruce E GerhardtBoard director

Reported raises · per SEC filings

Form D private placements

$3.2M disclosed across 2 of 6 rounds · 2015–2019

▶$10.1MofferedJun 2019 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bruce E. GerhardtDirector
  • Ivor RoystonDirector
  • Bruce HuebnerDirector
  • Lyle ArnoldExecutive Officer
  • Michael TerryExecutive Officer
  • Edwin HendrickExecutive Officer
  • Michael NallExecutive Officer, Director
  • Timothy KennedyExecutive Officer
  • David HaleDirector
  • M. Faye WilsonDirector
  • Marsha A. ChandlerDirector
Offering amount
$10.1M
First sale
May 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.4MofferedMar 2019 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ivor RoystonDirector
  • M. Faye WilsonDirector
  • Timothy KennedyExecutive Officer
  • Bruce HuebnerDirector
  • Michael NallExecutive Officer, Director
  • Marsha A. ChandlerDirector
  • Lyle ArnoldExecutive Officer
  • David HaleDirector
  • Edwin HendrickExecutive Officer
  • Michael TerryExecutive Officer
  • Bruce E. GerhardtDirector
Offering amount
$7.4M
Sales commissions
$489.1K
Finders' fees
$50K
First sale
Mar 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.4MofferedOct 2018 · 4 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • M. Faye WilsonDirector
  • Bruce HuebnerDirector
  • Michael NallExecutive Officer, Director
  • Michael TerryExecutive Officer
  • Marsha A. ChandlerDirector
  • Bruce E. GerhardtDirector
  • Edwin HendrickExecutive Officer
  • David HaleDirector
  • Ivor RoystonDirector
  • Lyle ArnoldExecutive Officer
  • Tim KennedyExecutive Officer
Offering amount
$2.4M
Finders' fees
$175.2K
First sale
Sep 2018
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.2MraisedAug 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Veena SinghExecutive Officer
  • Bruce HuebnerDirector
  • Michael NallExecutive Officer, Director
  • Lyle ArnoldExecutive Officer
  • Ed NeffDirector
  • Marsha A. ChandlerDirector
  • M. Faye WilsonDirector
  • Bruce E. GerhardtDirector
  • David HaleDirector
  • Ivor RoystonDirector
  • Michael TerryExecutive Officer
  • Tim KennedyExecutive Officer
Offering amount
$4.4M
Amount sold
$2.2M
Finders' fees
$110K
First sale
Aug 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.4MofferedApr 2017 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ivor RoystonDirector
  • Bruce HuebnerDirector
  • Veena SinghExecutive Officer
  • Michael TerryExecutive Officer
  • Lyle ArnoldExecutive Officer
  • Tim KennedyExecutive Officer
  • Bruce E. GerhardtDirector
  • Michael NallExecutive Officer, Director
  • Marsha A. ChandlerDirector
  • Ed NeffDirector
  • David HaleDirector
  • M. Faye WilsonDirector
Offering amount
$5.4M
Sales commissions
$557.3K
Finders' fees
$75K
First sale
Mar 2017
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedDec 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Edward NeffDirector
  • Michael W NallExecutive Officer, Director
  • Lyle ArnoldExecutive Officer
  • Bruce A HuebnerDirector
  • Marsha A ChandlerDirector
  • David F HaleDirector
  • Raaj TrivediExecutive Officer
  • M Faye WilsonDirector
  • Veena SinghExecutive Officer
  • Mark FolettaExecutive Officer
  • Ivor RoystonDirector
  • Bruce E GerhardtDirector
Offering amount
$15M
Amount sold
$1M
First sale
Dec 2015
Incorporated
Corporation, Delaware, 2013
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Biocept sets sights on expansion, fueled by COVID-19 testing - San Diego Regional EDCsandiegobusiness.org · May 2021Biocept raises around $10.3 million through a further registered direct share offering with several institutional investors | NASDAQ:BIOCproactiveinvestors.com · Apr 2020Biocept Closes Initial Public Offering, Raises $19M in Gross Proceeds | GenomeWebgenomeweb.com · Feb 2014Buy Biocept Inc Stock – BIOCQ Stock Quote Today & Investment Insights - Public.compublic.com

Frequently asked questions

How much funding has Biocept raised?
Biocept has disclosed $3.2M raised across 2 of its 6 known rounds.
Where is Biocept headquartered?
Biocept is headquartered in San Diego, US.